Mitochondrial pyrimidine nucleotide carrier (PNC1) regulates mitochondrial biogenesis and the invasive phenotype of cancer cells

被引:75
作者
Favre, C. [1 ]
Zhdanov, A. [2 ]
Leahy, M. [1 ]
Papkovsky, D. [2 ]
O'Connor, R. [1 ]
机构
[1] Univ Coll Cork, BioSci Inst, Dept Biochem, Cell Biol Lab, Cork, Ireland
[2] Univ Coll Cork, Dept Biochem, Lab Biophys & Bioanal, Cork, Ireland
基金
爱尔兰科学基金会;
关键词
PNC1; IGF-I; mitochondria; ROS; EMT in cancer; metabolism; ACTIVATED PROTEIN-KINASE; EPITHELIAL-MESENCHYMAL TRANSITION; GROWTH-FACTOR-I; AEROBIC GLYCOLYSIS; SKELETAL-MUSCLE; OXIDATIVE STRESS; DNA-REPLICATION; INSULIN; METABOLISM; OXYGEN;
D O I
10.1038/onc.2010.146
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
070307 [化学生物学]; 071010 [生物化学与分子生物学];
摘要
The insulin-like growth factor (IGF-I) signalling pathway is essential for metabolism, cell growth and survival. It induces expression of the mitochondrial pyrimidine nucleotide carrier 1 (PNC1) in transformed cells, but the consequences of this for cell phenotype are unknown. Here we show that PNC1 is necessary to maintain mitochondrial function by controlling mitochondrial DNA replication and the ratio of transcription of mitochondrial genes relative to nuclear genes. PNC1 suppression causes reduced oxidative phosphorylation and leakage of reactive oxygen species (ROS), which activates the AMPK-PGC1 alpha signalling pathway and promotes mitochondrial biogenesis. Overexpression of PNC1 suppresses mitochondrial biogenesis. Suppression of PNC1 causes a profound ROS-dependent epithelial-mesenchymal transition (EMT), whereas overexpression of PNC1 suppresses both basal EMT and induction of EMT by TGF-beta. Overall, our findings indicate that PNC1 is essential for mitochondria maintenance and suggest that its induction by IGF-I facilitates cell growth whereas protecting cells from an ROS-promoted differentiation programme that arises from mitochondrial dysfunction. Oncogene (2010) 29, 3964-3976; doi:10.1038/onc.2010.146; published online 10 May 2010
引用
收藏
页码:3964 / 3976
页数:13
相关论文
共 46 条
[1]
TOPK promotes tumour cell proliferation through p38MAPK activity and regulation of the DNA damage response [J].
Ayllon, V. ;
O'Connor, R. .
ONCOGENE, 2007, 26 (24) :3451-3461
[2]
Mitochondrial mutations in cancer [J].
Brandon, M. ;
Baldi, P. ;
Wallace, D. C. .
ONCOGENE, 2006, 25 (34) :4647-4662
[3]
Mitochondrial signaling: The retrograde response [J].
Butow, RA ;
Avadhani, NG .
MOLECULAR CELL, 2004, 14 (01) :1-15
[4]
Mitochondrial DNA mutations in human cancer [J].
Chatterjee, A. ;
Mambo, E. ;
Sidransky, D. .
ONCOGENE, 2006, 25 (34) :4663-4674
[5]
Inherited mitochondrial diseases of DNA replication [J].
Copeland, William C. .
ANNUAL REVIEW OF MEDICINE, 2008, 59 :131-146
[6]
Brick by brick: metabolism and tumor cell growth [J].
DeBerardinis, Ralph J. ;
Sayed, Nabil ;
Ditsworth, Dara ;
Thompson, Craig B. .
CURRENT OPINION IN GENETICS & DEVELOPMENT, 2008, 18 (01) :54-61
[7]
Akt stimulates aerobic glycolysis in cancer cells [J].
Elstrom, RL ;
Bauer, DE ;
Buzzai, M ;
Karnauskas, R ;
Harris, MH ;
Plas, DR ;
Zhuang, HM ;
Cinalli, RM ;
Alavi, A ;
Rudin, CM ;
Thompson, CB .
CANCER RESEARCH, 2004, 64 (11) :3892-3899
[8]
DNA replication and transcription in mammalian mitochondria [J].
Falkenberg, Maria ;
Larsson, Nils-Goeran ;
Gustafsson, Claes M. .
ANNUAL REVIEW OF BIOCHEMISTRY, 2007, 76 :679-699
[9]
Pro-metastatic signaling by c-Met through RAC-1 and reactive oxygen species (ROS) [J].
Ferraro, D. ;
Corso, S. ;
Fasano, E. ;
Panieri, E. ;
Santangelo, R. ;
Borrello, S. ;
Giordano, S. ;
Pani, G. ;
Galeotti, T. .
ONCOGENE, 2006, 25 (26) :3689-3698
[10]
Redox-dependent signal transduction [J].
Finkel, T .
FEBS LETTERS, 2000, 476 (1-2) :52-54